PDE4 inhibitor rolipram dynamically regulates the balance between D1-MSNs and D2-MSNs in the DMS to modulate abnormal “Go” behavior associated with alcohol addiction

Acta Pharmacologica Sinica 2026 Open access

Read full text

Authors: Wei Zhao, Shuang Zhao, Zi-qi Wang, Xiao-fei Chen, Fangjiao Zong, Han‐Ting Zhang

DOI: 10.1038/s41401-025-01738-w

Cited by: 0

References: 75

Fields of Study & Subjects

Neurotransmitter Receptor Influence on Behavior Phosphodiesterase function and regulation Neuroscience and Neuropharmacology Research

References 75